Price rise for anti-allergy EpiPen sparks furor
A five-fold price hike for EpiPen, which allergy sufferers use to counteract life-threatening reactions, has made Mylan the newest drugmaker to come under attack in the United States for profiteering.
Aug 23, 2016
1
3